NCT04950218Recruiting
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
PSOCADIA: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Source: ClinicalTrials.gov · Last updated 15 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 8 Dec 2020
- Start date
- 1 Sept 2021
- Primary completion date
- 1 Oct 2034
- Lead sponsor
- Herlev and Gentofte Hospital
- Diseases
- Psoriasis, Heart failure, Coronary artery disease, Stroke
- NCT number
- NCT04950218
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Sept 2021 to the primary completion date, 1 Oct 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients not able to cooperate to the study
- Patients unable understand and sign informed consent
Who the study is looking for
- Patients 18 years or older with a diagnosis of psoriasis will be invited to participate
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen Coordinator of this site? Confirm its status | Hellerup | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.